Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
crbp · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Buy
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$44.00
Consensus
$38.50
+409.3% upside
Low
$33.00
Median: $38.5 · Last Close: $7.56
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$38.50
409.3% upside
High Target
$44
482.0%
Low Target
$33
336.5%
Current Price
$7.56
as of today
Based on analyst price targets, the CRBP stock price prediction for the next 12 months ranges from $33 to $44. The consensus CRBP price forecast of $38.50 implies 409.3% upside from the current price of $7.56.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.18 | ↓ 5.00% |
1-day model range: $7.05–$7.31. Peak: $7.31 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -50.0% |
| 2028 | $3 | -62.5% |
| 2029 | $2 | -67.2% |
| 2030 | $2 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CRBP · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-27 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-22 | Mizuho | Maintains | Outperform→Outperform |
| 2026-05-13 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-05-13 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-13 | Jefferies | Maintains | Buy→Buy |
| 2026-03-10 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-11-13 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-10-20 | Wedbush | Maintains | Outperform→Outperform |
| 2025-10-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock. Of the recent 51 rating actions, 2 were upgrades and 3 were downgrades. 16 analysts currently cover CRBP.
Analyst Recommendation Trends
CRBP analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 6 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 63.1% YoY
Revenue Next Year
$4M
↑ 116.0% YoY
EPS This Year
$-4.64
EPS Next Year
$-5.15
↑ 10.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRBP EPS of $-4.64 for the current fiscal year, based on estimates from 8 analysts. The CRBP revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CRBP stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CRBP price target is $38.50 (+409.3% upside), with an analyst consensus of Buy.
The CRBP short-term stock prediction for tomorrow is $7.18 (-5.00%). The CRBP stock price prediction for 2027 estimates an average of $4. The CRBP stock prediction for 2030 projects a range of $2–$3.
Corbus Pharmaceuticals Holdings, Inc. trades on NASDAQ under the ticker CRBP. The CRBP stock outlook for 2027 is broadly positive, supported by a Buy consensus among 88% of covering analysts.
Frequently asked questions
CRBP forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month CRBP price target is $38.50, with a high forecast of $44.00 and a low of $33.00. The median price target is shown in the chart above when available. This implies +409.3% potential upside from the current price of $7.56.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.